ARTICLE | Company News
BioNTech acquiring MAB Discovery's antibody generation unit
January 23, 2019 10:02 AM UTC
BioNTech AG (Mainz, Germany) will acquire the antibody generation unit of MAB Discovery GmbH (Neuried, Germany) to expand its capabilities to rapidly produce new mAb candidates.
BioNTech will gain all of MAB Discovery's assets, employees and IP regarding mAb generation. MAB Discovery will retain its preclinical pipeline of immuno-oncology antibodies. Financial terms were not disclosed...